Add to ORKGBackground: Hypertension is a major risk factor for the development of stroke. It is well known that lowering blood pressure decreases the risk of stroke in people with moderate to severe hypertension. However, the specific effects of calcium channel blockers (CCBs) against stroke in patients with hypertension as compared to no treatment and other antihypertensive drug classes are not known. Methods and Findings: This systematic review and meta-analysis of randomized controlled trials (RCTs) evaluated CCBs effect on stroke in patients with hypertension in studies of CCBs versus placebo, angiotensin-converting-enzyme inhibitors (ACEIs), b-adrenergic blockers, and diuretics. The PUBMED, MEDLINE, EMBASE, OVID, CNKI, MEDCH, and WANFAN
[[abstract]]Background: Hypertension is the most important risk factor for stroke and stroke recurre...
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...
BACKGROUND: Hypertension is a major risk factor for the development of stroke. It is well known that...
Hypertension is a major risk factor for the development of stroke. It is well known that lowering bl...
BACKGROUND: The possibility that specific antihypertensive treatments may prevent the occurrence of ...
BACKGROUND: The possibility that specific antihypertensive treatments may prevent the occurrence of ...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
OBJECTIVES We present a meta-analysis based on three recent, substantial, randomized outcome trials ...
This review evaluates the current position of calcium channel blockers (CCB) in antihypertensive tre...
AbstractObjectivesWe present a meta-analysis based on three recent, substantial, randomized outcome ...
[[abstract]]Background: Hypertension is the most important risk factor for stroke and stroke recurre...
[[abstract]]Background: Hypertension is the most important risk factor for stroke and stroke recurre...
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...
BACKGROUND: Hypertension is a major risk factor for the development of stroke. It is well known that...
Hypertension is a major risk factor for the development of stroke. It is well known that lowering bl...
BACKGROUND: The possibility that specific antihypertensive treatments may prevent the occurrence of ...
BACKGROUND: The possibility that specific antihypertensive treatments may prevent the occurrence of ...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
Clinical studies have shown that calcium channel blockers (CCB) can mitigate the progression of athe...
OBJECTIVES We present a meta-analysis based on three recent, substantial, randomized outcome trials ...
This review evaluates the current position of calcium channel blockers (CCB) in antihypertensive tre...
AbstractObjectivesWe present a meta-analysis based on three recent, substantial, randomized outcome ...
[[abstract]]Background: Hypertension is the most important risk factor for stroke and stroke recurre...
[[abstract]]Background: Hypertension is the most important risk factor for stroke and stroke recurre...
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of...
The authors aimed to investigate the superiority of angiotensin system blockade (angiotensin-convert...